Chris Williamson interviews Dr. Jonathan Anomaly about embryo selection, exploring the reasons for public skepticism, the distinction between embryo selection and gene editing, and the ethical considerations surrounding the technology. They discuss the difference between screening for disease and traits like intelligence, the slippery slope towards eugenics, and the potential for genetic inequalities. Anomaly addresses concerns about rich people having genetically superior children and the role of government in regulating access to the technology. The conversation also covers the validation of polygenic scores, the potential for buyer's remorse, and the problem of personhood in the context of embryo selection, as well as the potential for increased stigma surrounding psychiatric conditions.
Part 1: Introduction and Ethical Concerns
Part 2: Democratization and Current Practices
Part 3: Validation and Efficacy of Polygenic Scores
Part 4: Culpability, Social Norms, and Ethical Boundaries
Part 5: Impact and Future Outlook
Part 6: Recommendation and Closing
Sign in to continue reading, translating and more.
Open full episode in Podwise